Related Experiment Video
Updated: Aug 17, 2026

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
Published on: January 8, 2015
Anchorless prion protein results in infectious amyloid disease without clinical scrapie
Bruce Chesebro1, Matthew Trifilo, Richard Race
1Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, Hamilton, MT 59840, USA. bchesebro@niaid.nih.gov
Abstract:
In prion and Alzheimer's diseases, the roles played by amyloid versus nonamyloid deposits in brain damage remain unresolved. In scrapie-infected transgenic mice expressing prion protein (PrP) lacking the glycosylphosphatidylinositol (GPI) membrane anchor, abnormal protease-resistant PrPres was deposited as amyloid plaques, rather than the usual nonamyloid form of PrPres. Although PrPres amyloid plaques induced brain damage reminiscent of Alzheimer's disease, clinical manifestations were minimal. In contrast, combined expression of anchorless and wild-type PrP produced accelerated clinical scrapie. Thus, the PrP GPI anchor may play a role in the pathogenesis of prion diseases.
Insights
The prion protein's GPI anchor influences prion disease. Amyloid plaques from anchorless PrP caused brain damage but minimal symptoms, while combined anchorless and wild-type PrP accelerated disease.
Area of Science:
- Neuroscience
- Biochemistry
- Pathology
Background:
- The roles of amyloid and nonamyloid deposits in prion and Alzheimer's diseases are unclear.
- Prion protein (PrP) aggregation is central to prion diseases.
Purpose of the Study:
- To investigate the role of the prion protein's glycosylphosphatidylinositol (GPI) anchor in prion disease pathogenesis.
- To determine if anchorless PrP aggregation into amyloid plaques affects disease characteristics.
Main Methods:
- Generated transgenic mice expressing anchorless PrP.
- Infected mice with scrapie agent.
- Analyzed PrP deposition (amyloid vs. nonamyloid) and clinical signs.
Main Results:
- Anchorless PrP formed abnormal protease-resistant PrPres deposits as amyloid plaques.
- These amyloid plaques induced brain damage similar to Alzheimer's disease but with minimal clinical manifestations.
- Combined expression of anchorless and wild-type PrP led to accelerated clinical scrapie.
Conclusions:
- The GPI anchor of PrP may be crucial for the typical pathogenesis of prion diseases.
- Amyloid plaque formation by anchorless PrP can cause neuropathology without severe clinical symptoms.
- Modulating PrP GPI anchor expression could be a therapeutic target for prion disorders.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Subviral Agents
Alzheimer Disease ll: Pathophysiology
Rabies
Lysosomal Hydrolases

